Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM
Garfield Alastair exercised options for 4,445 Rhythm Pharmaceuticals, Inc. shares (Form 4)
Traded Jul 1, 2026 · Filed Jul 2, 2026
On Jul 1, 2026, Garfield Alastair (Chief Scientific Officer) exercised options for 4,445 Rhythm Pharmaceuticals, Inc. shares, leaving 10,058 shares. Filed Jul 2, 2026 (Form 4).
- Options exercised
- 4,445 shares
- Holding after
- 10,058 shares
- Trading plan
- No
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Option exercise | 4,445 | 12,208 | Direct | |
| Jul 1, 2026 | Common Stock | Shares withheld for tax | 2,150 | US$110.41 | 10,058 | Direct |
Source
Related
- Rhythm Pharmaceuticals, Inc.
- Garfield Alastair
- Rhythm Pharmaceuticals, Inc. shareholders
- Form 4 · Garfield Alastair · Aug 17, 2026
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Meeker David P · Sep 14, 2026
- Form 4 · Smith Hunter C · Sep 1, 2026
- Form 4 · Shulman Joseph · Aug 17, 2026
- Form 4 · Lee Jennifer Kayden · Aug 14, 2026